Skip to main navigation Skip to search Skip to main content

Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects with Partial Epilepsy Not Well Controlled by Current Antiepiletic Drugs (P#093-046)

Grants and Contracts Details

StatusFinished
Effective start/end date11/18/10 → 3/31/15

Funding

  • Sunovion Pharmaceuticals Incorporated: $14,154.00